DuPont: Neutral Rating Was Correct, Post-Qnity Outlook

DuPont's neutral rating was correct. The company's focus on post-Qnity developments is a positive step. Chemical companies like BASF SE are leaders in the sector and worth considering for investment.

In the wake of escalating global trade tensions, chemical giants DuPont de Nemours and BASF SE are strategically repositioning their businesses to mitigate the impacts of tariffs and other geopolitical risks. While DuPont de Nemours has been the subject of recent institutional investments and positive analyst ratings, BASF SE is grappling with significant challenges due to the tariff environment.

DuPont de Nemours: Positive Institutional Investments and Analyst Ratings

DuPont de Nemours has seen a flurry of institutional activity in its stock, with several major investors increasing their stakes in the first quarter of 2025. Bridgewater Advisors Inc. acquired 8,492 shares valued at approximately $634,000, while Norges Bank, Marshall Wace LLP, Prudential Financial Inc., Assenagon Asset Management S.A., and Schroder Investment Management Group also made substantial purchases [1]. This increased interest is likely driven by the company's strong earnings performance, with a reported earnings per share (EPS) of $1.03 for the quarter ending May 2, 2025, surpassing the consensus estimate of $0.95 [1].

Analysts have also been bullish on DuPont de Nemours, with several firms upgrading their price targets and ratings. Mizuho, UBS Group, and JPMorgan Chase & Co. have all increased their price targets, with JPMorgan Chase & Co. raising its target from $78.00 to $93.00 and assigning an "overweight" rating [1]. The consensus rating is currently "Moderate Buy" with an average price target of $88.15 [1]. Despite these positive developments, the company's focus on post-Qnity developments is a significant factor for investors to consider.

BASF SE: Strategic Shifts Amid Tariff Turbulence

BASF SE, the world's largest chemical producer, has been forced to adapt its strategies in response to the recent escalation of U.S. tariffs on Chinese and European goods. The company's revised 2025 financial outlook reflects a 9.7% year-on-year drop in operating profit and a cut to its EBITDA forecast [2]. BASF's "local-for-local" strategy, which aims to reduce reliance on cross-border supply chains, is a notable response to these challenges. However, the company is facing indirect demand destruction and geopolitical volatility, which could further disrupt its operations and profitability.

The revised full-year EBITDA guidance of €7.3–7.7 billion highlights the structural threat posed by tariffs, with margin pressures from Chinese input tariffs and a weakening euro compounding the challenges [2]. BASF's cost-saving programs may buy time, but they risk diluting long-term growth if sustained indefinitely. The agricultural segment, which accounts for 15% of revenue, is already feeling the pinch, with tariffs on fertilizers and pesticides deterring buyers in India and Brazil [2].

Conclusion

While DuPont de Nemours has benefited from recent institutional investments and positive analyst ratings, the company's focus on post-Qnity developments is a critical factor for investors to consider. Meanwhile, BASF SE is navigating significant challenges due to the tariff environment, with its strategic shifts aimed at mitigating the impacts of trade tensions. Chemical companies like BASF SE, with diversified regional footprints and cost discipline, may outperform peers over the long term, but short-term volatility is inevitable. Investors should carefully weigh the risks and opportunities in this sector.

References

[1] https://www.marketbeat.com/instant-alerts/filing-bridgewater-advisors-inc-acquires-shares-of-8492-dupont-de-nemours-inc-nysedd-2025-07-16/
[2] https://www.ainvest.com/news/navigating-tariff-turbulence-basf-strategic-shifts-ripple-effects-chemical-sector-investments-2507/